These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 20864316

  • 1. Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjögren's syndrome-like sialoadenitis.
    Iizuka M, Wakamatsu E, Tsuboi H, Nakamura Y, Hayashi T, Matsui M, Goto D, Ito S, Matsumoto I, Sumida T.
    J Autoimmun; 2010 Dec; 35(4):383-9. PubMed ID: 20864316
    [Abstract] [Full Text] [Related]

  • 2. Functional role of M3 muscarinic acetylcholine receptor (M3R) reactive T cells and anti-M3R autoantibodies in patients with Sjögren's syndrome.
    Sumida T, Tsuboi H, Iizuka M, Nakamura Y, Matsumoto I.
    Autoimmun Rev; 2010 Jul; 9(9):615-7. PubMed ID: 20462524
    [Abstract] [Full Text] [Related]

  • 3. RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjögren's syndrome-like sialadenitis.
    Tahara M, Tsuboi H, Segawa S, Asashima H, Iizuka-Koga M, Hirota T, Takahashi H, Kondo Y, Matsui M, Matsumoto I, Sumida T.
    Clin Exp Immunol; 2017 Feb; 187(2):213-224. PubMed ID: 27643385
    [Abstract] [Full Text] [Related]

  • 4. The role of M3 muscarinic acetylcholine receptor reactive T cells in Sjögren's syndrome: a critical review.
    Sumida T, Tsuboi H, Iizuka M, Hirota T, Asashima H, Matsumoto I.
    J Autoimmun; 2014 Jun; 51():44-50. PubMed ID: 24397962
    [Abstract] [Full Text] [Related]

  • 5. The anergy induction of M3 muscarinic acetylcholine receptor-reactive CD4+ T cells suppresses experimental sialadenitis-like Sjögren's syndrome.
    Asashima H, Tsuboi H, Takahashi H, Hirota T, Iizuka M, Kondo Y, Matsui M, Matsumoto I, Sumida T.
    Arthritis Rheumatol; 2015 May; 67(8):2213-25. PubMed ID: 25891013
    [Abstract] [Full Text] [Related]

  • 6. Pathogenic role of anti-M3 muscarinic acetylcholine receptor immune response in Sjögren's syndrome.
    Sumida T, Iizuka M, Asashima H, Tsuboi H, Matsumoto I.
    Presse Med; 2012 Sep; 41(9 Pt 2):e461-6. PubMed ID: 22884125
    [Abstract] [Full Text] [Related]

  • 7. Role of immune response to M3 muscarinic acethylcholine receptor in the pathogenesis of Sjögren's syndrome.
    Iizuka M, Wakamatsu E, Matsumoto I, Tsuboi H, Nakamura Y, Matsui M, Sumida T.
    Nihon Rinsho Meneki Gakkai Kaishi; 2010 Sep; 33(2):87-91. PubMed ID: 20453444
    [Abstract] [Full Text] [Related]

  • 8. Evidence that anti-muscarinic antibodies in Sjögren's syndrome recognise both M3R and M1R.
    Schegg V, Vogel M, Didichenko S, Stadler MB, Beleznay Z, Gadola S, Sengupta C, Stadler BM, Miescher SM.
    Biologicals; 2008 Jul; 36(4):213-22. PubMed ID: 18249005
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antimuscarinic antibodies in primary Sjögren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells.
    Dawson LJ, Stanbury J, Venn N, Hasdimir B, Rogers SN, Smith PM.
    Arthritis Rheum; 2006 Apr; 54(4):1165-73. PubMed ID: 16572451
    [Abstract] [Full Text] [Related]

  • 16. [Anti-M3 muscarinic acetylcholine receptor antibodies and Sjögren's syndrome].
    Tsuboi H, Iizuka M, Asashima H, Sumida T.
    Nihon Rinsho Meneki Gakkai Kaishi; 2013 Apr; 36(2):77-85. PubMed ID: 23629427
    [Abstract] [Full Text] [Related]

  • 17. Passive transfer of Sjogren's syndrome IgG produces the pathophysiology of overactive bladder.
    Wang F, Jackson MW, Maughan V, Cavill D, Smith AJ, Waterman SA, Gordon TP.
    Arthritis Rheum; 2004 Nov; 50(11):3637-45. PubMed ID: 15529387
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.